arrow
返回
U

Urania Dafni

National and Kapodistrian University of Athens

66H指数
327论文数
1.5W被引数
收录论文 102
发表时间
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer25,946例非小细胞肺癌患者中NTRK融合的流行率及特征
err2026-06-28
err0
PREAI
errTeodora Radonic; Sepehr Rahmani-Khajouei; Urania Dafni; Albrecht Stenzinger; Martina Haberecker; Line Bille Madsen; Kim Monkhorst; Jacek Kowalski; Javier Hernandez-Losa; Keith M. Kerr; Ernst Jan M. Speel; Lukas Bubendorf; Leena Joseph; Atilio Navarro; Erik Thunnissen; Irene Sansano; Lisa M. Hillen; Wojciech Biernat; Miriam Christoffel; Lydia Tsamtsouri
err分享
err收藏
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)ESMO临床获益程度量表2.0版(ESMO-MCBS v2.0)
err2025-05-22
err0
PREAI
errN.I. Cherny; S.F. Oosting; U. Dafni; N.J. Latino; M. Galotti; P. Zygoura; G. Dimopoulou; T. Amaral; J. Barriuso; A. Calles; B. Kiesewetter; C. Gomez-Roca; B. Gyawali; M. Piccart; A. Passaro; F. Roitberg; N. Tarazona; D. Trapani; G. Curigliano; R. Wester; E.G.E. de Vries
err分享
err收藏
Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin 2 in advanced cutaneous melanoma: a systematic review and meta-analysis使用肿瘤浸润淋巴细胞联合高剂量重组白细胞介素2进行过继治疗在晚期皮肤黑色素瘤中的安全性:一项系统评价和Meta分析
err2025-04-08
err0
PREAI
errS. Martín-Lluesma; U. Dafni; K. Vervita; D. Karlis; G. Dimopoulou; Z. Tsourti; G. Villacampa; V. Galvao; J. Lostes; E. Muñoz-Couselo; M. Rotxés; X. Villalobos; S. Muñoz; J.B.A.G. Haanen; I.M. Svane; J.M. Piulats; J. Martin-Liberal; A. Gros; G. Coukos; E. Garralda
err分享
err收藏
A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial一项关于阿替利珠单抗、贝伐珠单抗和化疗在获得性耐药的EGFR突变非小细胞肺癌中的随机非对照II期研究——ETOP 15-19 ABC-lung试验
err2025-04-01
err0
PREAI
errSoo, R. A.; Vervita, K.; Fruh, M.; Cho, B. C.; Majem, M.; Abreu, D. Rodriguez; Ribi, K.; Callejo, A.; Moran, T.; Gomez, M. Domine; Provencio, M.; Addeo, A.; Han, J. Y.; Granados, A. L. Ortega; Reck, M.; Blasco, A.; Campelo, R. Garcia; Gonzalez, M. A. Sala; Britschgi, C.; Roschitzki-Voser, H.; Ruepp, B.; Gasca-Ruchti, A.; Haberecker, M.; Dafni, U.; Peters, S.; Stahel, R. A.
err分享
err收藏
Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis
err2024-10-01
err0
PREAI
errMartin-Lluesma, S.; Svane, I. M.; Dafni, U.; Vervita, K.; Karlis, D.; Dimopoulou, G.; Tsourti, Z.; Rohaan, M. W.; Haanen, J. B. A. G.; Coukos, G.
err分享
err收藏
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma对肿瘤浸润淋巴细胞过继治疗的反应与黑色素瘤中预先存在的CD8 T髓样细胞网络有关
err2024-02-02
err16
errOAAI
errBarras, David; Ghisoni, Eleonora; Chiffelle, Johanna; Orcurto, Angela; Dagher, Julien; Fahr, Noemie; Benedetti, Fabrizio; Crespo, Isaac; Grimm, Alizee J.; Morotti, Matteo; Zimmermann, Stefan; Duran, Rafael; Imbimbo, Martina; de Olza, Maria Ochoa; Navarro, Blanca; Homicsko, Krisztian; Bobisse, Sara; Labes, Danny; Tsourti, Zoe; Andriakopoulou, Charitini; Herrera, Fernanda; Petremand, Remy; Dummer, Reinhard; Berthod, Gregoire; Kraemer, Anne I.; Huber, Florian; Thevenet, Jonathan; Bassani-Sternberg, Michal; Schaefer, Niklaus; Prior, John O.; Matter, Maurice; Aedo, Veronica; Dromain, Clarisse; Corria-Osorio, Jesus; Tissot, Stephanie; Kandalaft, Lana E.; Gottardo, Raphael; Pittet, Mikael; Sempoux, Christine; Michielin, Olivier; Dafni, Urania; Trueb, Lionel; Harari, Alexandre; Laniti, Denarda Dangaj; Coukos, George
err分享
err收藏
ESMO Guidance for Reporting Oncology real-World evidence (GROW)报告肿瘤学真实世界证据的ESMO指南 (GROW)
err2023-12-01
err37
errOAAI
errCastelo-Branco, L.; Pellat, A.; Martins-Branco, D.; Valachis, A.; Derksen, J. W. G.; Suijkerbuijk, K. P. M.; Dafni, U.; Dellaporta, T.; Vogel, A.; Prelaj, A.; Groenwold, R. H. H.; Martins, H.; Stahel, R.; Bliss, J.; Kather, J.; Ribelles, N.; Perrone, F.; Hall, P. S.; Dienstmann, R.; Booth, C. M.; Pentheroudakis, G.; Delaloge, S.; Koopman, M.
err分享
err收藏
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study
err2023-11-08
err1
errOAAI
errMartins-Branco, Diogo; Kassapian, Marie; Debien, Veronique; Caparica, Rafael; Eiger, Daniel; Dafni, Urania; Andriakopoulou, Charitini; El-Abed, Sarra; Ellard, Susan L.; Izquierdo, Miguel; Vicente, Malou; Chumsri, Saranya; Piccart-Gebhart, Martine; Moreno-Aspitia, Alvaro; Knop, Ann Soegaard; Lombard, Janine; de Azambuja, Evandro
err分享
err收藏
PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesotheliomaPD-1-expressing巨噬细胞和CD8 T细胞是晚期间皮瘤PD-1抑制临床获益的独立预测因子
err2023-10-25
err3
errOAAI
errHomicsko, Krisztian; Zygoura, Panagiota; Norkin, Maxim; Tissot, Stephanie; Shakarishvili, Nicholas; Popat, Sanjay; Curioni-Fontecedro, Alessandra; O'Brien, Mary; Pope, Anthony; Shah, Riyaz; Fisher, Patricia; Spicer, James; Roy, Amy; Gilligan, David; Rusakiewicz, Sylvie; Fortis, Ekaterina; Marti, Nesa; Kammler, Roswitha; Finn, Stephen P.; Coukos, Georges; Dafni, Urania; Peters, Solange; Stahel, Rolf A.
err分享
err收藏
COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases癌症患者的新型冠状病毒肺炎: 来自esmo-cocare,BSMO和PSMO国际数据库联合分析的更新
err2023-06-01
err2
errOAAI
errMartin, P.; Tsourti, Z.; Ribeiro, J.; Castelo-Branco, L.; de Azambuja, E.; Gennatas, S.; Rogado, J.; Sekacheva, M.; Susnjal, S.; Vinal, D.; Lee, R.; Khallaf, S.; Dimopoulou, G.; Pradervand, S.; Whisenant, J.; Choueiri, T. K.; Arnold, D.; Harrington, K.; Punie, K.; Oliveira, J.; Michielin, O.; Dafni, U.; Peters, S.; Pentheroudakis, G.; Romano, E.
err分享
err收藏
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines尽管有高水平的证据,但标签外: 常用非专利癌症药物的临床实践回顾
err2023-02-01
err6
errOAAI
errZarkavelis, G.; Amylidi, A. L.; Verbaanderd, C.; Cherny, N. I.; Metaxas, Y.; Vries, E. G. E. de; Zygoura, P.; Amaral, T.; Jordan, K.; Strijbos, M.; Dafni, U.; Latino, N.; Galotti, M.; Lordick, F.; Giuliani, R.; Pignatti, F.; Pentheroudakis, G.
err分享
err收藏
PD-L1 expression and outcomes of pembrolizumab and placebo in completely resected stage IB-IIIA NSCLC: Subgroup analysis of PEARLS/KEYNOTE-091
err2022-09-01
err4
errOAAI
errPeters, S.; Besse, B.; Marreaud, S.; Dafni, U.; Oselin, K.; Havel, L.; Gonzalez, E. Esteban; Isla, D.; Martinez-Marti, A.; Faehling, M.; Tsuboi, M.; Lee, J-S.; Nakagawa, K.; Yang, J.; Keller, S. M.; Mauer, M. E.; Jha, N.; Stahel, R. A.; Paz-Ares, L.; O'Brien, M. E. R.
err分享
err收藏
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study
err2022-09-01
err1
errOAAI
errNader-Marta, Guilherme; Debien, Veronique; Eiger, Daniel; Tsourti, Zoi; Caparica, Rafael; Kassapian, Marie; Napoleone, Sylvia; Hultsch, Susanne; Korde, Larissa; Wang, Yingbo; Chumsri, Saranya; Pritchard, Kathleen, I; Untch, Michael; Bellet-Ezquerra, Meritxell; Rosa, Daniela Dornelles; Moreno-Aspitia, Alvaro; Piccart, Martine; Dafni, Urania; de Azambuja, Evandro
err分享
err收藏
Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC-a systematic review and meta-analysis
err2022-06-01
err11
errOAAI
errDafni, U.; Soo, R. A.; Peters, S.; Tsourti, Z.; Zygoura, P.; Vervita, K.; Han, J-Y; De Castro, J.; Coate, L.; Fruh, M.; Hashemi, S. M. S.; Nadal, E.; Carcereny, E.; Sala, M. A.; Bernabe, R.; Provencio, M.; Cuffe, S.; Roschitzki-Voser, H.; Ruepp, B.; Rosell, R.; Stahel, R. A.
err分享
err收藏
err分享
err收藏
The first ones now, will later be last: understanding the importance of historical context when reading ESMO-MCBS scores
err2022-04-01
err1
errOAAI
errCherny, N., I; Dafni, U.; Pentheroudakis, G.; Piccart, M.; Zygoura, P.; Gyawali, B.; de Vries, E. G. E.
err分享
err收藏
Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC: A systematic review and meta-analysis
err2022-04-01
err0
errOAAI
errDafni, U.; Soo, R. A.; Peters, S.; Tsourti, Z.; Vervita, K.; Han, J-Y.; De Castro, J.; Coate, L.; Frueh, M.; Hashemi, S. M. S.; Nadal, E.; Carcereny, E.; Sala Gonzalez, M. Angeles; Bernabe Caro, R.; Provencio Pulla, M.; Cuffe, S.; Ruepp, B.; Roschitzki-Voser, H.; Rosell, R.; Stahel, R. A.
err分享
err收藏
VP3-2022: Pembrolizumab (pembro) versus placebo for early-stage non-small cell lung cancer (NSCLC) following complete resection and adjuvant chemotherapy (chemo) when indicated: Randomized, triple-blind, phase III EORTC-1416-LCG/ETOP 8-15 e PEARLS/KEYNOTE-091 study
err2022-04-01
err62
errOAAI
errPaz-Ares, L.; O'Brien, M. E. R.; Mauer, M.; Dafni, U.; Oselin, K.; Havel, L.; Gonzalez, E. Esteban; Isla, D.; Martinez-Marti, A.; Faehling, M.; Tsuboi, M.; Lee, J-s.; Nakagawa, K.; Yang, J.; Keller, S. M.; Jha, N.; Marreaud, S. I.; Stahel, R. A.; Peters, S.; Besse, B.
err分享
err收藏
The impact of erythropoietin administration concomitantly with adjuvant anti-HER2 treatment on the patients' outcome: Sub-analysis of the ALTTO study
err2022-02-15
err0
PREAI
errMartins-Branco, Diogo; Kassapian, Marie; Debien, Veronique; Caparica, Rafael; Eiger, Daniel; Dafni, Urania; Andriakopoulou, Charitini; El-Abed, Sarra; Izquierdo, Miguel; Vicente, Malou; Chumsri, Saranya; Piccart-Gebhart, Martine; Moreno-Aspitia, Alvaro; Knop, Ann Soegaard; Lombard, Janine; de Azambuja, Evandro
err分享
err收藏